AVITA Medical (RCEL) CFO boosts direct stake to 152,927 shares
Rhea-AI Filing Summary
AVITA Medical, Inc. (RCEL) officer David D. O'Toole, the CFO, reported an amended insider transaction. On June 12, 2026, he purchased 2,000 shares of AVITA Medical common stock at $3.97 per share in an open market or private transaction. This amendment corrects the original filing’s transaction code from “A” to “P”. Following the purchase, his directly held position is 152,927 shares, which includes unvested RSUs.
Positive
- None.
Negative
- None.
Insider Trade Summary
Net Buyer: 2,000 shares
Net Buy
1 txn
Insider
O'Toole David D
Role
CFO
Bought
2,000 shs ($8K)
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Purchase | Common Stock F1, F2 | 2,000 | $3.97 | $8K |
Holdings After Transaction:
Common Stock — 152,927 shares (Direct)
Footnotes (2)
- F1. The original Form 4, filed on June 12, 2026, inadvertently used transaction code 'A' instead of transaction code 'P'. This amendment corrects the transaction code.
- F2. Includes unvested RSUs
Key Figures
Shares purchased: 2,000 shares
Purchase price per share: $3.97 per share
Shares held after transaction: 152,927 shares
+1 more
4 metrics
Shares purchased
2,000 shares
Common Stock purchase on June 12, 2026
Purchase price per share
$3.97 per share
Open market or private transaction on June 12, 2026
Shares held after transaction
152,927 shares
Direct holdings after June 12, 2026 transaction, includes unvested RSUs
Net buy shares reported
2,000 shares
Net buy direction across all transactions in this Form 4/A
Key Terms
Form 4/A, transaction code, RSUs, open market or private transaction
4 terms
Form 4/A regulatory
"The original Form 4, filed on June 12, 2026, inadvertently used"
Form 4/A is an amended filing that corrects or updates an earlier Form 4, the mandatory report that insiders (like company executives, directors, or large shareholders) must file when their ownership stakes change. Think of it as an edited receipt showing who bought or sold stock and when; investors use it to track insider confidence, detect potential conflicts, and spot trading patterns that might signal future company prospects.
transaction code regulatory
"inadvertently used transaction code 'A' instead of transaction code 'P'"
RSUs financial
"Includes unvested RSUs"
RSUs, or restricted stock units, are a form of company shares given to employees as part of their compensation. They are typically awarded with certain restrictions, such as a waiting period before they can be fully owned or sold, similar to earning a gift that becomes fully yours over time. For investors, RSUs can impact a company's stock offerings and reflect how much the company relies on stock-based incentives to attract and retain talent.
open market or private transaction market
"transaction code 'P' describes a Purchase in open market or private transaction"
FAQ
What insider transaction did RCEL CFO David O'Toole report in this Form 4/A?
He reported a purchase of 2,000 shares of AVITA Medical, Inc. common stock on June 12, 2026, classified as a purchase in an open market or private transaction at a price of $3.97 per share.
Why was this Form 4/A filing for RCEL an amendment?
The filing states that the original Form 4 filed on June 12, 2026 inadvertently used transaction code “A” instead of transaction code “P”. This amendment corrects the transaction code to properly reflect a purchase.
Was the RCEL insider transaction made under a Rule 10b5-1 trading plan?
The document-level checkbox for Rule 10b5-1 is not checked, and the footnotes do not state that the June 12, 2026 purchase was made pursuant to a Rule 10b5-1 trading plan.
AI-generated analysis. How Rhea-AI works. Not financial advice.
